Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | MAP2K1 |
Variant | N109_Q110del |
Impact List | deletion |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | MAP2K1 N109_Q110del results in the deletion of two amino acids in the protein kinase domain of the Map2k1 protein from amino acids 109 to 110 (UniProt.org). N109_Q110del results in increased Erk phosphorylation in cultured cells (PMID: 32641410), and therefore, is predicted to lead to a gain of Map2k1 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
MAP2K1 mutant MAP2K1 act mut MAP2K1 N109_Q110del |
Transcript | NM_002755.4 |
gDNA | chr15:g.66436780_66436785delACCAGA |
cDNA | c.326_331delACCAGA |
Protein | p.N109_Q110delNQ |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011521783 | chr15:g.66436845_66436850delGGTGCG | c.325_330delGGTGCG | p.G109_A110delGA | RefSeq | GRCh38/hg38 |
XM_017022413 | chr15:g.66485149_66485154delGAGACC | c.325_330delGAGACC | p.E109_T110delET | RefSeq | GRCh38/hg38 |
XM_017022412 | chr15:g.66436845_66436850delGGTGCG | c.325_330delGGTGCG | p.G109_A110delGA | RefSeq | GRCh38/hg38 |
NM_002755.4 | chr15:g.66436780_66436785delACCAGA | c.326_331delACCAGA | p.N109_Q110delNQ | RefSeq | GRCh38/hg38 |
XM_017022413.1 | chr15:g.66485149_66485154delGAGACC | c.325_330delGAGACC | p.E109_T110delET | RefSeq | GRCh38/hg38 |
XM_011521783.3 | chr15:g.66436845_66436850delGGTGCG | c.325_330delGGTGCG | p.G109_A110delGA | RefSeq | GRCh38/hg38 |
XM_011521783.4 | chr15:g.66436845_66436850delGGTGCG | c.325_330delGGTGCG | p.G109_A110delGA | RefSeq | GRCh38/hg38 |
XM_017022411 | chr15:g.66436780_66436785delACCAGA | c.326_331delACCAGA | p.N109_Q110delNQ | RefSeq | GRCh38/hg38 |
NM_002755 | chr15:g.66436780_66436785delACCAGA | c.326_331delACCAGA | p.N109_Q110delNQ | RefSeq | GRCh38/hg38 |
XM_017022411.2 | chr15:g.66436780_66436785delACCAGA | c.326_331delACCAGA | p.N109_Q110delNQ | RefSeq | GRCh38/hg38 |
NM_002755.3 | chr15:g.66436780_66436785delACCAGA | c.326_331delACCAGA | p.N109_Q110delNQ | RefSeq | GRCh38/hg38 |
XM_017022411.3 | chr15:g.66436780_66436785delACCAGA | c.326_331delACCAGA | p.N109_Q110delNQ | RefSeq | GRCh38/hg38 |
NM_001411065.1 | chr15:g.66436845_66436850delGGTGCG | c.325_330delGGTGCG | p.G109_A110delGA | RefSeq | GRCh38/hg38 |
XM_017022412.1 | chr15:g.66436845_66436850delGGTGCG | c.325_330delGGTGCG | p.G109_A110delGA | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|